The units bought by Abbott Laboratories are accused of submitting false Medicare claims for unnecessary devices for diabetic patients and paying kickbacks to the patients.
The units bought by Abbott Laboratories are accused of submitting false Medicare claims for unnecessary devices for diabetic patients and paying kickbacks to the patients.